103 related articles for article (PubMed ID: 16445664)
61. Conventional endometrioid adenocarcinomas of the endometrium recurring as clear cell tumors: comparative immunohistochemical analyses.
Rawish KR; Desouki MM; Crispens MA; Fadare O
Ann Diagn Pathol; 2013 Jun; 17(3):270-5. PubMed ID: 23394889
[TBL] [Abstract][Full Text] [Related]
62. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
[TBL] [Abstract][Full Text] [Related]
63. Endometrial cytopathology. An image analysis approach using the Ki-67 biomarker.
Apostolou G; Apostolou N; Moulos P; Chatzipantelis P
Cytopathology; 2017 Oct; 28(5):385-390. PubMed ID: 28737230
[TBL] [Abstract][Full Text] [Related]
64. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
[TBL] [Abstract][Full Text] [Related]
65. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
Mielcarek-Kuchta D; Olofsson J; Golusinski W
Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
[TBL] [Abstract][Full Text] [Related]
66. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
67. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
Silva EG; Young RH
Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
[TBL] [Abstract][Full Text] [Related]
68. Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.
Bonneterre J; Hutt E; Bosq J; Graham JD; Powell MA; Leblanc E; Fujiwara K; Herzog TJ; Coleman RL; Clarke CL; Gilles EM; Zukiwski AA; Monk BJ
Gynecol Oncol; 2015 Sep; 138(3):663-7. PubMed ID: 26142884
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
70. Sarcomatous Transformation in Undifferentiated/Dedifferentiated Endometrial Carcinoma: An Underrecognized Phenomenon and Diagnostic Pitfall.
Vroobel KM; Attygalle AD
Int J Gynecol Pathol; 2020 Sep; 39(5):485-492. PubMed ID: 31567540
[TBL] [Abstract][Full Text] [Related]
71. Cyclin E is overexpressed by clear cell carcinomas of the endometrium and is a prognostic indicator of survival.
Zapiecki K; Manahan KJ; Miller GA; Geisler JP
Eur J Gynaecol Oncol; 2015; 36(2):114-6. PubMed ID: 26050345
[TBL] [Abstract][Full Text] [Related]
72. Clear cell adenocarcinoma of the tongue.
Fujita H; Iida M; Imura J; Shinagawa Y; Omotehara F; Kawamata H; Imai Y; Fujimori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Nov; 98(5):579-82. PubMed ID: 15529130
[TBL] [Abstract][Full Text] [Related]
73. Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma.
Santala S; Talvensaari-Mattila A; Soini Y; Santala M
Tumour Biol; 2015 Feb; 36(2):953-7. PubMed ID: 25315186
[TBL] [Abstract][Full Text] [Related]
74. VALIDATION OF A PANEL OF BIOMARKERS ASSOCIATED WITH AGGRESSIVE PHENOTYPE OF ENDOMETRIOID CARCINOMA OF ENDOMETRIUM.
Buchynska LG; Iurchenko NP; Nesina IP; Glushchenko NM
Exp Oncol; 2022 Nov; 44(3):234-238. PubMed ID: 36325701
[TBL] [Abstract][Full Text] [Related]
75. Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: case report with molecular analysis.
Barisella M; Lampis A; Perrone F; Carbone A
World J Gastroenterol; 2008 Nov; 14(42):6575-7. PubMed ID: 19030216
[TBL] [Abstract][Full Text] [Related]
76. Vesical clear cell adenocarcinoma. V. Nephrogenic adenoma: a diagnostic problem.
Alsanjari N; Lynch MJ; Fisher C; Parkinson MC
Histopathology; 1995 Jul; 27(1):43-9. PubMed ID: 7557905
[TBL] [Abstract][Full Text] [Related]
77. Difficulties of clinical and histopathological diagnosis in advanced vulvar clear cell carcinoma.
Herghelegiu CG; Neacşu A; Oprescu ND; Cărbunaru AE; Brăila AD; Curea FG; Marcu ML; Ioan RG; Bohîlţea RE
Rom J Morphol Embryol; 2018; 59(4):1233-1237. PubMed ID: 30845306
[TBL] [Abstract][Full Text] [Related]
78. Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract.
Vang R; Whitaker BP; Farhood AI; Silva EG; Ro JY; Deavers MT
Int J Gynecol Pathol; 2001 Jul; 20(3):252-9. PubMed ID: 11444201
[TBL] [Abstract][Full Text] [Related]
79. Cervical adenocarcinoma with clear cell morphology. report of six cases and literature review.
Kondi-Pafiti A; Kairi-Vassilatou E; Bakalianou K; Iavazzo C; Kleanthis Ch; Hasiakos D; Liapis A
Eur J Gynaecol Oncol; 2011; 32(1):107-10. PubMed ID: 21446339
[TBL] [Abstract][Full Text] [Related]
80. Unusual CCA-stem structure of E. coli B tRNAH(His)(1).
Harada F; Sato S; Nishimura S
FEBS Lett; 1972 Jan; 19(4):352-354. PubMed ID: 11946249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
